NCT06011369

Brief Summary

In thyroid surgery, the identification and preservation of the parathyroid glands and their vascularization is essential to avoid postoperative hypoparathyroidism. In this sense, fluorescence technology with autofluorescence (AF) can help us avoid this post-surgical complication. This study aims to determine the advantages offered by fluorescence in thyroid surgery, taking into account various clinical variables. For this, a randomized study is proposed in patients undergoing thyroid surgery with and without cervical fluorescence.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
260

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

August 25, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

September 6, 2023

Status Verified

September 1, 2023

Enrollment Period

1 year

First QC Date

August 1, 2023

Last Update Submit

September 1, 2023

Conditions

Outcome Measures

Primary Outcomes (10)

  • Type of surgery performed

    total thyroidectomy/hemithyroidectomy; lymphadenectomy

    Up to 12 months.

  • Number of parathyroid glands identified before the use of AF (Autofluorescence)

    Gland count

    Up to 12 months.

  • Number and location of parathyroid glands identified with the use of FA (Autofluorescence)

    Gland count

    Up to 12 months.

  • Quantification of each parathyroid gland with AF(Autofluorescence)

    (two determinations in the same parathyroid gland, in total, eight determinations of the parathyroid glands parathyroid, and three determinations in the thyroid gland, the last being in a nodule if it'd exist

    Up to 12 months.

  • Number of glands accidentally removed.

    Gland count

    Up to 12 months.

  • Number of autotransplanted glands.

    Gland count

    Up to 12 months.

  • Surgical time.

    Hours of surgery

    Up to 12 months.

  • Number of previous thyroidectomies performed with FA (Autofluorescence)(learning curve)

    Number of surgeries using autofluorescence

    Up to 12 months.

  • Concentration of PTH and calcium corrected by albumin and/or ionic

    Value in analytics

    4, 24 Hours

  • Concentration of PTH and calcium corrected by albumin and/or ionic

    Value in analytics

    6,12 Months

Study Arms (2)

Fluorescence in thyroid surgery

EXPERIMENTAL

Patients undergoing thyroid surgery with cervical fluorescence.

Procedure: Fluorescence in thyroid surgery

No Fluorescence in thyroid surgery

NO INTERVENTION

patients undergoing thyroid surgery without cervical fluorescence.

Interventions

Fluorescence in thyroid surgery

Fluorescence in thyroid surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Total thyroidectomy with/without lymph node dissection
  • Signature of informed consent

You may not qualify if:

  • Patients under 18 years of age
  • Hemithyroidectomy
  • Reintervention of thyroid surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clínico Universitario Virgen de la Arrixaca

Murcia, 30120, Spain

RECRUITING

MeSH Terms

Interventions

Fluorescence

Intervention Hierarchy (Ancestors)

LuminescenceLightElectromagnetic RadiationElectromagnetic PhenomenaMagnetic PhenomenaPhysical PhenomenaOptical Phenomena

Study Officials

  • Beatriz Febrero, MD

    HCUVA

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Beatriz Febrero, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: PROSPECTIVE, CONTROLLED, RANDOMIZED
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2023

First Posted

August 25, 2023

Study Start

August 1, 2023

Primary Completion

August 1, 2024

Study Completion

December 1, 2024

Last Updated

September 6, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations